Pivotal Study in Advanced Parkinsons Disease Patients

NCT00466167 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

517

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: Pramipexol Extended Release
DRUG: Pramipexol Immediate Release
DRUG: Placebo

Sponsor

Boehringer Ingelheim